Whether you’re an established multinational or an emerging player poised to change the world, corporations and their boards are facing unprecedented scrutiny from governments and regulators. Amid this evolving and increasingly interconnected regulatory landscape, cutting-edge U.S. and multinational technology and life sciences companies across growth stages turn to Fenwick for guidance through high-stakes white collar criminal cases and regulatory investigations—as well as sensitive internal corporate investigations.

Fenwick’s securities enforcement group represents public companies and other regulated entities and their boards, officers and employees in investigations or proceedings by the Securities and Exchange Commission (SEC), the U.S. Department of Justice (DOJ) and other governmental and self-regulatory agencies. We also conduct high-stakes and often time-sensitive internal investigations for public and private multinational corporate boards and management in response to possible insider trading, accounting fraud, Foreign Corrupt Practice Act (FCPA) violations or other alleged misconduct.

Our team applies judgment honed over hundreds of matters to guide clients through complex litigation, investigations and related business challenges.

Many of the world’s most innovative technology and life sciences companies have trusted Fenwick to successfully handle their thorniest securities litigation and related investigations. Our lawyers understand that securities litigation can pose significant strategic, financial and reputational challenges, and we partner with clients to develop creative, efficient and effective litigation strategies and resolutions.